Bullish
Gilead buys Arcellx (ACLX) for $115 per share plus $5 CVR
Gilead Sciences has completed its acquisition of Arcellx (ACLX) for $115 per share in cash, plus a contingent value right (CVR) of an additional $5 up...
Gilead Sciences has completed its acquisition of Arcellx (ACLX) for $115 per share in cash, plus a contingent value right (CVR) of an additional $5 up...